Literature DB >> 19679834

NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells.

Katrin Schröder1, Andreas Kohnen, Alexandra Aicher, Elisa A Liehn, Tom Büchse, Stefan Stein, Christian Weber, Stefanie Dimmeler, Ralf P Brandes.   

Abstract

RATIONALE: Endothelial progenitor cells (EPCs, defined as sca-1(+)flk-1(+)lin(-) mononuclear blood cells) contribute to vascular repair. The role of hypoxia and reactive oxygen species (ROS) in mobilization and function of these cells is incompletely understood.
OBJECTIVE: We studied the contribution of the NADPH oxidase Nox2, an important vascular source of ROS in this context. METHODS AND
RESULTS: Hypoxia (10% oxygen) induced the mobilization of EPCs in wild-type (WT) and Nox1 but not in Nox2 knockout (Nox2(y/-)) mice. As erythropoietin (EPO) is known to induce EPC mobilization, we focused on this hormone. EPO induced the mobilization of EPCs in WT and Nox1(y/-) but not Nox2(y/-) animals. Transplantation of bone marrow from Nox2(y/-) mice into WT-mice blocked mobilization in response to hypoxia and EPO, whereas transplantation of WT bone marrow into Nox2(y/-) mice restored mobilization. Reendothelialization of the injured mouse carotid artery was enhanced by hypoxia as well as by EPO, and this effect was not observed in Nox2(y/-) mice or after transplantation of Nox2(y/-) bone marrow. In cultured EPCs from WT but not Nox2(y/-) mice, EPO induced ROS production, migration, and proliferation. EPO signaling involves the STAT5 transcription factor. EPO-induced STAT5-dependent reporter gene expression was absent in Nox2-deficient cells. siRNA against the redox-sensitive phosphatase SHP-2 restored EPO-mediated STAT5 induction and inhibition of SHP-2 restored EPO-induced migration in Nox2-deficient cells
CONCLUSIONS: We conclude that Nox2-derived ROS inactivate SHP-2 and thereby facilitate EPO signaling in EPCs to promote hypoxia-induced mobilization and vascular repair by these cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679834     DOI: 10.1161/CIRCRESAHA.109.205138

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  47 in total

Review 1.  The Nox family of NADPH oxidases: friend or foe of the vascular system?

Authors:  Ina Takac; Katrin Schröder; Ralf P Brandes
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  Endothelial progenitor cells=EPC=elemental pernicious complexity.

Authors:  Ralf P Brandes; Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

Review 3.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

Review 4.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 5.  Generation of reactive oxygen species in adipose-derived stem cells: friend or foe?

Authors:  Sang Gyu Park; Ji Hye Kim; Ying Xia; Jong-Hyuk Sung
Journal:  Expert Opin Ther Targets       Date:  2011-10-10       Impact factor: 6.902

6.  MiR-27b augments bone marrow progenitor cell survival via suppressing the mitochondrial apoptotic pathway in Type 2 diabetes.

Authors:  Hainan Li; Jenny Liu; Yihan Wang; Zhiyao Fu; Maik Hüttemann; Terrence J Monks; Alex F Chen; Jie-Mei Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-11       Impact factor: 4.310

7.  Primary involvement of NADPH oxidase 4 in hypoxia-induced generation of reactive oxygen species in adipose-derived stem cells.

Authors:  Ji Hye Kim; Seung-Yong Song; Sang Gyu Park; Sun U Song; Ying Xia; Jong-Hyuk Sung
Journal:  Stem Cells Dev       Date:  2012-02-03       Impact factor: 3.272

Review 8.  NADPH oxidases-do they play a role in TRPC regulation under hypoxia?

Authors:  Monika Malczyk; Christine Veith; Ralph T Schermuly; Thomas Gudermann; Alexander Dietrich; Natascha Sommer; Norbert Weissmann; Oleg Pak
Journal:  Pflugers Arch       Date:  2015-10-01       Impact factor: 3.657

9.  Levosimendan attenuates pulmonary vascular remodeling.

Authors:  M Revermann; M Schloss; A Mieth; A Babelova; K Schröder; S Neofitidou; J Buerkl; T Kirschning; R T Schermuly; C Hofstetter; R P Brandes
Journal:  Intensive Care Med       Date:  2011-05-31       Impact factor: 17.440

10.  Cross-kingdom comparison of transcriptomic adjustments to low-oxygen stress highlights conserved and plant-specific responses.

Authors:  Angelika Mustroph; Seung Cho Lee; Teruko Oosumi; Maria Eugenia Zanetti; Huijun Yang; Kelvin Ma; Arbi Yaghoubi-Masihi; Takeshi Fukao; Julia Bailey-Serres
Journal:  Plant Physiol       Date:  2010-01-22       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.